Quick Answer
RenovoRx, Inc. reported Total Assets of $8.10 million for fiscal year 2025.
RenovoRx, Inc. Total Assets — Annual History
| Fiscal Year | Total Assets | YoY Change |
|---|---|---|
| 2025 | $8.10M | -0.3% |
| 2024 | $8.12M | +453.8% |
| 2023 | $1.47M | -79.8% |
| 2022 | $7.26M | -55.4% |
| 2021 | $16.29M | +750.9% |
| 2020 | $1.91M | — |
Quarterly Total Assets
| Quarter Ending | Total Assets | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | $11.21M | +11.7% | -17.9% |
| June 30, 2025 | $13.64M | +13.7% | -14.8% |
| March 31, 2025 | $16.01M | +234.5% | +97.3% |
| December 31, 2024 | $8.12M | +453.8% | -19.1% |
| September 30, 2024 | $10.03M | +185.1% | -16.4% |
| June 30, 2024 | $12.00M | +90.1% | +150.7% |
| March 31, 2024 | $4.79M | +5.0% | +226.6% |
| December 31, 2023 | $1.47M | -79.8% | -58.3% |
- RenovoRx, Inc. showed a decrease of -0.3% in Total Assets compared to the prior fiscal year.
- Over the 2020–2025 period, RenovoRx, Inc.’s total assets has grown by 322.9% (from $1.91 million to $8.10 million).
- The most recent figure is from RenovoRx, Inc.’s fiscal year 2025 report (Form 10-K), filed with the SEC on March 30, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: